CG Oncology (CGON) Earnings Date & Reports

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGON is expected to report earnings to fall 15.49% to -60 cents per share on August 07

Q2'26

Est.

$-0.60

Q1'26

Missed

by $0.11

Q4'25

Missed

by $0.07

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.12

The last earnings report on May 08 showed earnings per share of -70 cents, missing the estimate of -60 cents. With 181.77K shares outstanding, the current market capitalization sits at 6.27B.

View a ticker or compare two or three

CGON

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days